Efficacy and Safety of HD-tDCS and Respiratory Rehabilitation for Critically Ill Patients with COVID-19 The HD-RECOVERY Randomized Clinical Trial

Background And Purpose: Acute Respiratory Distress Syndrome (ADRS) due to coronavirus disease 2019 (COVID-19) has been associated with muscle fatigue, corticospinal pathways dysfunction, and mortality. High-Definition transcranial Direct Current Stimulation (HD-tDCS) may be used to attenuate clinical impairment in these patients. The HD-RECOVERY randomized clinical trial was conducted to evaluate the efficacy and safety of HD-tDCS with respiratory rehabilitation in patients with moderate to severe ARDS due to COVID-19.

Methods: Fifty-six critically ill patients were randomized 1:1 to active (n = 28) or sham (n = 28) HD-tDCS (twice a day, 30-min, 3-mA) plus respiratory rehabilitation for up to 10 days or until intensive care unit discharge. The primary outcome was ventilator-free days during the first 28 days, defined as the number of days free from mechanical ventilation. Furthermore, secondary outcomes such as delirium, organ failure, hospital length of stay and adverse effects were investigated.

Results: Active HD-tDCS induced more ventilator-free days compared to sham HD-tDCS. Patients in the active group vs in the sham group experienced lower organ dysfunction, delirium, and length of stay rates over time. In addition, positive clinical response was higher in the active vs sham group. There was no significant difference in the prespecified secondary outcomes at 5 days. Adverse events were similar between groups.

Conclusions: Among patients with COVID-19 and moderate to severe ARDS, use of active HD-tDCS compared with sham HD-tDCS plus respiratory rehabilitation resulted in a statistically significant increase in the number of ventilator-free days over 28 days. HD-tDCS combined with concurrent rehabilitation therapy is a safe, feasible, potentially add-on intervention, and further trials should examine HD-tDCS efficacy in a larger sample of patients with COVID-19 and severe hypoxemia.

Citing Articles

Influence of bilateral transcranial direct-current stimulation on muscle strength and respiratory endurance: Randomized, placebo-controlled, double-blind trial protocol.

Pereira E, Areas F, Kuster E, Maia M, da Silva J, Norbim L MethodsX. 2024; 13:102939.

PMID: 39398535 PMC: 11470191. DOI: 10.1016/j.mex.2024.102939.

Direct current stimulation as a non-invasive therapeutic alternative for treating autonomic or non-autonomic neurological disorders affecting breathing.

Delucenay-Clarke R, Nierat M, Frugiere A, Similowski T, Cayetanot F, Bodineau L Clin Auton Res. 2024; 34(4):395-411.

PMID: 39133345 DOI: 10.1007/s10286-024-01055-y.

Transcranial direct current stimulation (tDCS) in the treatment of neuropsychiatric symptoms of long COVID.

Klirova M, Adamova A, Biackova N, Laskov O, Renkova V, Stuchlikova Z Sci Rep. 2024; 14(1):2193.

PMID: 38272997 PMC: 10810850. DOI: 10.1038/s41598-024-52763-4.

Rehabilitation and COVID-19: systematic review by Cochrane Rehabilitation.

Arienti C, Lazzarini S, Andrenelli E, Cordani C, Negrini F, Pollini E Eur J Phys Rehabil Med. 2024; 59(6):800-818.

PMID: 38214047 PMC: 10792873. DOI: 10.23736/S1973-9087.23.08331-4.

[Expert consensus on the clinical treatment of burn patients complicated with Coronavirus infection (2023 version)].

Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023; 39(8):701-712.

PMID: 37805779 PMC: 11630228. DOI: 10.3760/cma.j.cn501225-20230519-00176.

References

Ostergaard L . SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep. 2021; 9(3):e14726. PMC: 7849453. DOI: 10.14814/phy2.14726. View

Zirpe K, Tiwari A, Gurav S, Deshmukh A, Suryawanshi P, Wankhede P . Timing of Invasive Mechanical Ventilation and Mortality among Patients with Severe COVID-19-associated Acute Respiratory Distress Syndrome. Indian J Crit Care Med. 2021; 25(5):493-498. PMC: 8196392. DOI: 10.5005/jp-journals-10071-23816. View

Wachter D, Wrede A, Schulz-Schaeffer W, Taghizadeh-Waghefi A, Nitsche M, Kutschenko A . Transcranial direct current stimulation induces polarity-specific changes of cortical blood perfusion in the rat. Exp Neurol. 2010; 227(2):322-7. DOI: 10.1016/j.expneurol.2010.12.005. View

Khadka N, Bikson M . Neurocapillary-Modulation. Neuromodulation. 2020; 25(8):1299-1311. PMC: 8213863. DOI: 10.1111/ner.13338. View

Ramani C, Davis E, Kim J, Provencio J, Enfield K, Kadl A . Post-ICU COVID-19 Outcomes: A Case Series. Chest. 2020; 159(1):215-218. PMC: 7442057. DOI: 10.1016/j.chest.2020.08.2056. View

. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013; 310(20):2191-4. DOI: 10.1001/jama.2013.281053. View

Ambrosino N, Venturelli E, Vagheggini G, Clini E . Rehabilitation, weaning and physical therapy strategies in chronic critically ill patients. Eur Respir J. 2011; 39(2):487-92. DOI: 10.1183/09031936.00094411. View

Reis J, Fritsch B . Modulation of motor performance and motor learning by transcranial direct current stimulation. Curr Opin Neurol. 2011; 24(6):590-6. DOI: 10.1097/WCO.0b013e32834c3db0. View

Bahr-Hosseini M, Bikson M . Neurovascular-modulation: A review of primary vascular responses to transcranial electrical stimulation as a mechanism of action. Brain Stimul. 2021; 14(4):837-847. DOI: 10.1016/j.brs.2021.04.015. View

10.

Gandevia S, Rothwell J . Activation of the human diaphragm from the motor cortex. J Physiol. 1987; 384:109-18. PMC: 1192253. DOI: 10.1113/jphysiol.1987.sp016445. View

11.

Sakr Y, Lobo S, Moreno R, Gerlach H, Ranieri V, Michalopoulos A . Patterns and early evolution of organ failure in the intensive care unit and their relation to outcome. Crit Care. 2012; 16(6):R222. PMC: 3672601. DOI: 10.1186/cc11868. View

12.

Pilloni G, Bikson M, Badran B, George M, Kautz S, Okano A . Update on the Use of Transcranial Electrical Brain Stimulation to Manage Acute and Chronic COVID-19 Symptoms. Front Hum Neurosci. 2020; 14:595567. PMC: 7689057. DOI: 10.3389/fnhum.2020.595567. View

13.

Bikson M, Grossman P, Thomas C, Zannou A, Jiang J, Adnan T . Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016. Brain Stimul. 2016; 9(5):641-661. PMC: 5007190. DOI: 10.1016/j.brs.2016.06.004. View

14.

Beduneau G, Pham T, Schortgen F, Piquilloud L, Zogheib E, Jonas M . Epidemiology of Weaning Outcome according to a New Definition. The WIND Study. Am J Respir Crit Care Med. 2016; 195(6):772-783. DOI: 10.1164/rccm.201602-0320OC. View

15.

Pisani M, Murphy T, Araujo K, Van Ness P . Factors associated with persistent delirium after intensive care unit admission in an older medical patient population. J Crit Care. 2010; 25(3):540.e1-7. PMC: 2939229. DOI: 10.1016/j.jcrc.2010.02.009. View

16.

Elsayed H, Hassaballa A, Ahmed T, Gumaa M, Sharkawy H, Moharram A . Variation in outcome of invasive mechanical ventilation between different countries for patients with severe COVID-19: A systematic review and meta-analysis. PLoS One. 2021; 16(6):e0252760. PMC: 8177443. DOI: 10.1371/journal.pone.0252760. View

17.

Tomczak C, Greidanus K, Boliek C . Modulation of chest wall intermuscular coherence: effects of lung volume excursion and transcranial direct current stimulation. J Neurophysiol. 2013; 110(3):680-7. DOI: 10.1152/jn.00723.2012. View

18.

Dmochowski J, Datta A, Bikson M, Su Y, Parra L . Optimized multi-electrode stimulation increases focality and intensity at target. J Neural Eng. 2011; 8(4):046011. DOI: 10.1088/1741-2560/8/4/046011. View

19.

Tornero C, Pastor E, Garzando M, Orduna J, Forner M, Bocigas I . Non-invasive Vagus Nerve Stimulation for COVID-19: Results From a Randomized Controlled Trial (SAVIOR I). Front Neurol. 2022; 13:820864. PMC: 9028764. DOI: 10.3389/fneur.2022.820864. View

20.

Teasdale G, Jennett B . Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974; 2(7872):81-4. DOI: 10.1016/s0140-6736(74)91639-0. View